TAL1 and acute lymphoblastic leukemia: These T-ALL malignancies can be sub-grouped based on the distinct expression of various transcription factors, such as TAL1/TAL2, TLX1/TLX3, HOXA, and LMO1/LYL1, collectively known as type-A abnormalities (24).